Azenta Inc (AZTA) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences industry in the United States, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
Total Assets Chart for Azenta Inc
Azenta Inc (AZTA) total assets for FY2025 were USD 2.1B, a -1.9% change from FY2024. Azenta Inc's total assets grew from USD 12.8M in 1994 to USD 2.1B in 2025 (15990.5% over 31 years). Total assets compound annual growth rate: 5-year CAGR of 5.7%, 10-year CAGR of 10.5%, 20-year CAGR of 6.2%.
Total Assets (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $1.60B
- Implied Share Price
- $36.50
- Enterprise Value
- $1.05B
- Revenue (TTM)
- $613.81M
- EBITDA
- $33.01M
- Profit Margin
- -20.02%
- Trailing P/E
- —
- Forward P/E
- 29.07
- Price/Book (MRQ)
- 0.87
- Price/Sales (TTM)
- 2.61
- EV/EBITDA
- 31.86
- EV/Revenue
- 1.71
- Dividend Yield
- —
- Book Value
- $34.51
- Free Cash Flow (FY2025)
- $38.32M
- Free Cash Flow Yield
- 2.40%
Snapshot as of 24th October 2026 — not point-in-time controlled, may lag the live market by a few days.